A consecutive priming-boosting vaccination of mice with simian immunodeficiency virus (SIV) gag/pol DNA and recombinant vaccinia virus strain DIs elicits effective anti-SIV immunity.
about
The evolution of poxvirus vaccinesCharacterization of Antibody Responses to Combinations of a Dengue Virus Type 2 DNA Vaccine and Two Dengue Virus Type 2 Protein Vaccines in Rhesus MacaquesVaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.Mycobacterial codon optimization enhances antigen expression and virus-specific immune responses in recombinant Mycobacterium bovis bacille Calmette-Guérin expressing human immunodeficiency virus type 1 Gag.Priming-boosting vaccination with recombinant Mycobacterium bovis bacillus Calmette-Guérin and a nonreplicating vaccinia virus recombinant leads to long-lasting and effective immunity.Sequential immunization with V3 peptides from primary human immunodeficiency virus type 1 produces cross-neutralizing antibodies against primary isolates with a matching narrow-neutralization sequence motif.Mycobacterium bovis Bacille Calmette-Guérin as a Vaccine Vector for Global Infectious Disease ControlHIV-1 Subtype C Mosaic Gag Expressed by BCG and MVA Elicits Persistent Effector T Cell Responses in a Prime-Boost Regimen in MicePrime-boost vaccinations using recombinant flavivirus replicon and vaccinia virus vaccines: an ELISPOT analysis.Recombinant vaccinia DIs expressing simian immunodeficiency virus gag and pol in mammalian cells induces efficient cellular immunity as a safe immunodeficiency virus vaccine candidate.Effect of therapeutic immunization using Ad5/35 and MVA vectors on SIV infection of rhesus monkeys undergoing antiretroviral therapy.
P2860
Q26995905-97068572-FB2F-4071-AB54-2832518F3BEFQ27477541-077B132C-F585-4A13-BA0A-FC37885AA50BQ33717525-9991A8A4-50D0-4077-BC68-BEEB64230BDDQ33883995-476C43D7-57CA-4F23-AEBE-57EABD553484Q34045678-2B488220-D549-4FB4-B0F7-8372B3ABF70FQ34648342-6A2FB4E4-8CFB-4DFB-9B82-37FF7B4BDE87Q35909944-E1E50CE4-DFBB-4459-AD9B-A16AC874FF2AQ36079913-AB57CF8C-0CC8-4624-9588-CF4ABBB4F63CQ42998966-4BBD751D-877C-492B-BB26-C4F1FD764C03Q45408958-CA0C40F0-CB39-4C06-B433-5B1E034AF281Q45880914-E54ED72A-EEDE-498A-9E5C-FBA17E3F3EED
P2860
A consecutive priming-boosting vaccination of mice with simian immunodeficiency virus (SIV) gag/pol DNA and recombinant vaccinia virus strain DIs elicits effective anti-SIV immunity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A consecutive priming-boosting ...... s effective anti-SIV immunity.
@en
A consecutive priming-boosting vaccination of mice with simian immunodeficiency virus
@nl
type
label
A consecutive priming-boosting ...... s effective anti-SIV immunity.
@en
A consecutive priming-boosting vaccination of mice with simian immunodeficiency virus
@nl
prefLabel
A consecutive priming-boosting ...... s effective anti-SIV immunity.
@en
A consecutive priming-boosting vaccination of mice with simian immunodeficiency virus
@nl
P2093
P2860
P1433
P1476
A consecutive priming-boosting ...... s effective anti-SIV immunity.
@en
P2093
Kazuhiro Matsuo
Ke-Qin Xin
Kenji Okuda
Kenji Someya
Mitsuo Honda
P2860
P304
P356
10.1128/JVI.78.18.9842-9853.2004
P407
P577
2004-09-01T00:00:00Z